Quick Tip: Post-market surveillance is an active process not passively monitoring complaints
Insight from a conversation with Taylor Dieringer
Listen to the full podcast here
LTR 46: Tips to boost effectiveness of medical device post-market surveillance
“Risk management is often seen as a check the box activity”. Taylor Dieringer reminds us in this Let’s Talk Risk! conversation that risk management should be an ongoing, continuous process within your quality management system, that monitors, evaluates and controls risk throughout the product lifecycle, and not just in the pre-market phase.